Haematologica

Haematologica www.haematologica.org publishes novel findings in basic, clinical and translational hematology research. Impact Factor (JCR) 7.116 (7th of 76)

Haematologica/The Hematology Journal (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435) publishes peer-reviewed papers across all areas of experimental and clinical hematology. The journal is owned by a non-profit organization, the Ferrata Storti Foundation, and serves the scientific community strictly following the International Committee of Medical Journal Editors (ICMJE, www.icmje.org) recom

mendations on publication ethics policies for medical journals. Haematologica was founded in 1920 by Adolfo Ferrata

A young woman with acute lymphoblastic leukemia and severe PEG-asparaginase-induced hyperammonemia: how plasma exchange ...
28/07/2025

A young woman with acute lymphoblastic leukemia and severe PEG-asparaginase-induced hyperammonemia: how plasma exchange removed the excess ammonia, reversed neurological symptoms, and allowed continuation of leukemia treatment.
https://haematologica.org/article/view/11976

The case of a 78-year-old male patient with multiple myeloma type IgGλ who received multiple therapy regimes unravels th...
25/07/2025

The case of a 78-year-old male patient with multiple myeloma type IgGλ who received multiple therapy regimes unravels the role of carflizomib as a trigger for pulmonary complications.
https://haematologica.org/article/view/11943

A recent study using patient-derived xenograft models demonstrated that combining allopurinol with 6‑mercaptopurine sign...
22/07/2025

A recent study using patient-derived xenograft models demonstrated that combining allopurinol with 6‑mercaptopurine significantly reduces liver toxicity and improves event-free survival in children with acute lymphoblastic leukemia. An important step forward in childhood leukemia care.
https://haematologica.org/article/view/11905

A new study from the University Medical Center Hamburg–Eppendorf analyzes differences in outcome in patients with steroi...
19/07/2025

A new study from the University Medical Center Hamburg–Eppendorf analyzes differences in outcome in patients with steroid-refractory acute graft‑versus‑host disease treated with ruxolitinib with or without extracorporeal photopheresis. Find here the important results reported by Iryna Lastovytska and colleagues.
https://haematologica.org/article/view/11990

What do megakaryocytes do? A new review explores recent literature that expands our knowledge of megakaryocyte different...
16/07/2025

What do megakaryocytes do? A new review explores recent literature that expands our knowledge of megakaryocyte differentiation and heterogeneity, as well as the functions of megakaryocytes, with special focus on their immune functions and supporting roles for stressed or diseased hematopoietic stem cells.
https://haematologica.org/article/view/12004

Bispecific antibodies in diffuse large B-cell lymphoma (DLBCL): read the new review about CD20xCD3 bispecific antibodies...
14/07/2025

Bispecific antibodies in diffuse large B-cell lymphoma (DLBCL): read the new review about CD20xCD3 bispecific antibodies as treatment for DLBCL, the clinical data resulting in their approval in relapsed and refractory disease, and the evolving trial landscape that may bring this class of therapy into earlier lines of treatments.
https://haematologica.org/article/view/11929

Bispecific antibodies in follicular lymphoma: read the new review of available efficacy and safety data on bispecific an...
11/07/2025

Bispecific antibodies in follicular lymphoma: read the new review of available efficacy and safety data on bispecific antibodies for follicular lymphoma, their role in the current treatment landscape, and potential future clinical opportunities.
https://haematologica.org/article/view/haematol.2024.285245

Pros and cons: is there still a role for maintenance therapy in high-risk acute promyelocytic leukemia patients? Read th...
09/07/2025

Pros and cons: is there still a role for maintenance therapy in high-risk acute promyelocytic leukemia patients? Read the CONS by Harry J. Iland, with his perspective “Enough is enough, provided it’s the right stuff”.
https://haematologica.org/article/view/12013

Landmark paper in Hematology: in 1916, Paul Kaznelson described the first case of splenectomy in a patient with immune t...
03/07/2025

Landmark paper in Hematology: in 1916, Paul Kaznelson described the first case of splenectomy in a patient with immune thrombocytopenia. His hazardous courage made splenectomy a life-saving treatment for several thousands of patients.
https://haematologica.org/article/view/12128

The emerging problem of infections after bispecific T-cell engager treatment in multiple myeloma: a case series of four ...
26/06/2025

The emerging problem of infections after bispecific T-cell engager treatment in multiple myeloma: a case series of four patients developing non-tuberculous mycobacterial infections following teclistamab.
https://haematologica.org/article/view/11933

Indirizzo

Via Giuseppe Belli 4
Pavia
27100

Orario di apertura

Lunedì 09:00 - 18:00
Martedì 09:00 - 18:00
Mercoledì 09:00 - 18:00
Giovedì 09:00 - 18:00
Venerdì 09:00 - 18:00

Telefono

+39038227129

Sito Web

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Haematologica pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Haematologica:

Scelte rapide

Condividi